LifeMD Inc (LFMD)

LifeMD, Inc. is a healthcare technology company listed on the NASDAQ under the ticker LFMD. The company operates a direct-to-patient telehealth business in the United States, giving patients access to virtual medical care and pharmacy services. Its platform includes Rex MD, which focuses on men’s health concerns such as erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety, as well as ShapiroMD, which provides virtual treatment and related products for male and female hair loss. LifeMD also operates LifeMD PC, a virtual primary care and telehealth service designed to support primary care, urgent care, and chronic care needs. Additional services include on-demand consultations, prescriptions, diagnostics and imaging, wellness coaching, integration with in-home tools, GLP-1 weight management support, and in-home health monitoring devices. The company was founded in 1994 and is headquartered in New York, New York. It was formerly known as Conversion Labs, Inc. before adopting the LifeMD name in February 2021.


Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-LFMD
$4.52
40.4% Upside
Undervalued
$8.13
152.3% Upside
Bargain
Fair
0.0%
November 11, 2026
19.5x
0.8x
155.4 M
136.1 M
3.8%
82.3%
-2.8
1,545.3%
31.5%
Valuation • Fair Value

LifeMD Inc (NASDAQ-LFMD) Fair Value by Valuation Model

Review the available estimates for LifeMD Inc (NASDAQ-LFMD), including DCF Fair Value, EPV Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$4.52

Estimated upside of 40.4% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$5.32

Discounted cash flow valuation reference.

EPV Fair Value

$4.08

Earnings power value estimate.

Comps Fair Value

$3.80

Comparable-company valuation reference.

Analyst Price Target

$8.13

Analysts imply upside of 152.3%.

How to read these valuation models

Use the 6 available valuation references for LifeMD Inc (NASDAQ-LFMD) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for LifeMD Inc (NASDAQ-LFMD)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

191.6 M

Current operating scale indicator.

Revenue Forecast

207.4 M

Forward revenue estimate.

EBITDA

-18.955 M

Current operating profitability reference.

EBITDA Forecast

-3.467 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review LifeMD Inc (NASDAQ-LFMD) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for LifeMD Inc (NASDAQ-LFMD)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-3.60

No elevated caution signal from this screen.

Altman Z-Score

-2.8

Lower score that deserves closer risk review.

FCF / Net Income

31.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for LifeMD Inc (NASDAQ-LFMD). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for LifeMD Inc (NASDAQ-LFMD)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 11, 2026

Days to Earnings

54

Dividend Yield

0.0%

No current dividend yield is indicated.

Payout Ratio

1,545.3%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for LifeMD Inc (NASDAQ-LFMD), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

LifeMD Inc (NASDAQ-LFMD) Stock Forecast & Technical Outlook

Review LifeMD Inc (NASDAQ-LFMD) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for LifeMD Inc (NASDAQ-LFMD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for LifeMD Inc (NASDAQ-LFMD) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for LifeMD Inc (NASDAQ-LFMD) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for LifeMD Inc (NASDAQ-LFMD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for LifeMD Inc (NASDAQ-LFMD) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for LifeMD Inc (NASDAQ-LFMD)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, LifeMD Inc (NASDAQ-LFMD) has a Strong Buy consensus, with 8 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 8
Hold 0
Sell 0
FAQ Fast Investor Answers

LifeMD Inc (NASDAQ-LFMD) Stock FAQ

Data-supported answers about LifeMD Inc (NASDAQ-LFMD), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$4.52
Estimated upside 40.4%
Valuation Rating
Undervalued
Estimated upside of 40.4%
Analyst Target
$8.13
Implied upside 152.3%
Financial Health
Fair
Current financial-health read

The current fair value estimate for LifeMD Inc (NASDAQ-LFMD) is $4.52. This implies an estimated upside of 40.4% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 40.4% versus the current market price.

The available analyst price target for LifeMD Inc (NASDAQ-LFMD) is $8.13. The analyst target implies estimated upside of 152.3%.

The current financial health read for LifeMD Inc (NASDAQ-LFMD) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for LifeMD Inc (NASDAQ-LFMD) is November 11, 2026.

The latest available data indicates no current dividend yield for LifeMD Inc (NASDAQ-LFMD).

The current market capitalization listed for LifeMD Inc is 155.4 M.

The current enterprise value listed for LifeMD Inc is 136.1 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for LifeMD Inc is NASDAQ-LFMD, and the stock is listed on NASDAQ.

LifeMD Inc (NASDAQ-LFMD) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for LifeMD Inc is 3.8%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for LifeMD Inc is 82.3%. Free float helps investors understand how much of the share base is available for public trading.